secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apimeds Pharmaceuticals US, Inc. (APUS)
CIK:        0001894525
Form:       8-K
Filed at:   2025-06-05T23:59:59+00:00
Accession:  0001213900-25-051567
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Apimeds Pharmaceuticals appoints Erick J. Frim as CFO, replacing Mark Corrao
----------------------------------------------------------------------------

- Erick J. Frim, 67, appointed CFO effective May 30, 2025, succeeding Mark Corrao.
- Mr. Frim has over 40 years of financial management experience, most recently as interim CFO of Helio Corporation.
- Compensation: $2,500 per month for first 8 hours, $250 per hour thereafter under a one-year consulting agreement.
- No familial relationships or reportable related-party transactions with the Company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1894525/000121390025051567/0001213900-25-051567-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1894525/000121390025051567/ea024484201-8k_apimeds.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-051567

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer